Title:
BENZOXAZINE-4-ONE COMPOUND, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/160138
Kind Code:
A1
Abstract:
The present invention relates to a benzoxazine-4-one compound represented by formula (I) that acts as a glycogen phosphorylase inhibitor, a preparation method therefor, and a use thereof in a drug for the treatment and/or prevention of diseases associated with glycogen metabolism abnormalities.
Inventors:
ZHANG LIYING (CN)
Application Number:
PCT/CN2021/074002
Publication Date:
August 04, 2022
Filing Date:
January 27, 2021
Export Citation:
Assignee:
UNIV CHENGDE MEDICAL (CN)
International Classes:
C07D413/12; A61K31/536; A61K31/537; A61P3/10; A61P5/50; A61P9/12; A61P13/12; A61P25/28; A61P35/00; C07D471/04
Domestic Patent References:
| WO2006059164A2 | 2006-06-08 | |||
| WO2014097188A1 | 2014-06-26 |
Foreign References:
| CN103497181A | 2014-01-08 | |||
| CN112442022A | 2021-03-05 | |||
| EP1452526A1 | 2004-09-01 | |||
| CN101622231A | 2010-01-06 | |||
| CN1826340A | 2006-08-30 |
Other References:
DATABASE REGISTRY 7 February 2012 (2012-02-07), ANONYMOUS : "1H-Indole-2-carboxamide, 6-ethoxy-N-(1,2,3,4-tetrahydro-1-oxo-7- isoquinolinyl)-(CA INDEX NAME) ", XP055954994, retrieved from STN Database accession no. 1355639-22-3
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: